AllianceBernstein
SLXP

AllianceBernstein’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

AllianceBernstein’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-50,641
Closed -$8.75M – 3544
2015
Q1 		$8.75M Sell
50,641
-23,571
-32% -$3.46M 0.01% 933
2014
Q4 		$8.53M Buy
74,212
+7,424
+11% +$899K 0.01% 929
2014
Q3 		$10.4M Buy
66,788
+15,331
+30% +$2.22M 0.01% 870
2014
Q2 		$6.35M Sell
51,457
-1,790
-3% -$198K 0.01% 1020
2014
Q1 		$5.52M Buy
53,247
+2,951
+6% +$302K ﹤0.01% 1084
2013
Q4 		$4.52M Sell
50,296
-6,127
-11% -$489K ﹤0.01% 1167
2013
Q3 		$3.77M Buy
56,423
+10,296
+22% +$709K ﹤0.01% 1242
2013
Q2 		$3.05M Buy
+46,127
New +$2.64M ﹤0.01% 1321

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

AllianceBernstein's SLXP Position: Q2 2015 in Review

AllianceBernstein sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 50,641 shares — an estimated $8.75M sold.

AllianceBernstein first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $10.4M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • AllianceBernstein reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • AllianceBernstein sold 50,641 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $8.75M.
  • AllianceBernstein first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • AllianceBernstein's SALIX PHARMACEUTICALS LTD DEL position peaked at $10.4M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on AllianceBernstein's 13F filing for Q2 2015, filed 14 Aug 2015.